Pekin Hardy Strauss Inc. bought a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,775 shares of the company’s stock, valued at approximately $1,481,000. A number of other institutional investors and hedge […]